Discontinued — last reported Q2 '25

Products & Services · Collaboration revenues

Epkinly — Collaboration revenues

AbbVie Epkinly — Collaboration revenues increased by 36.1% to $49.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 69.0%, from $29.00M to $49.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2021
Last reportedQ2 2025Aug 4, 2025

How to read this metric

An increase indicates successful commercialization or development milestones achieved through partnerships, while a decrease may suggest reduced partnership activity or the expiration of collaborative terms.

Detailed definition

This metric represents the portion of total revenue generated from Epkinly that is derived from collaborative arrangemen...

Peer comparison

Similar to 'collaboration revenue' or 'partnered product revenue' reported by other pharmaceutical companies engaged in co-development or co-promotion agreements.

Metric ID: abbv_segment_epkinly_collaboration_revenues

Historical Data

15 periods
 Q2 '21Q3 '21Q4 '21Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$14.00M$14.00M$22.00M$29.00M$31.00M$36.00M$36.00M$49.00M
QoQ Change+0.0%+57.1%+31.8%+6.9%+16.1%+0.0%+36.1%
YoY Change+121.4%+157.1%+63.6%+69.0%
Range$0.00$49.00M
Avg YoY Growth+102.8%
Median YoY Growth+95.2%
Current Streak7+ quarters growth

Frequently Asked Questions

What is AbbVie's epkinly — collaboration revenues?
AbbVie (ABBV) reported epkinly — collaboration revenues of $49.00M in Q2 2025.
How has AbbVie's epkinly — collaboration revenues changed year-over-year?
AbbVie's epkinly — collaboration revenues increased by 69.0% year-over-year, from $29.00M to $49.00M.
What does epkinly — collaboration revenues mean?
Revenue earned from Epkinly through joint ventures or partnership agreements with other companies.